Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 959 | 1074 | 1039 | 985 | 1252 | 1349 |
Fund Return | -4.14% | 7.4% | 3.86% | -0.51% | 4.6% | 3.04% |
Place in category | 309 | 196 | 287 | 474 | 365 | 329 |
% in Category | 33 | 21 | 31 | 72 | 70 | 89 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
AB Large Cap Growth Advisor | 13.26B | 13.41 | 11.60 | 16.16 | ||
AB International Strat Eqs Adv | 6.5B | 12.56 | 3.80 | - | ||
AB Large Cap Growth Z | 6.07B | 13.42 | 11.68 | - | ||
AB Intermediate Diversified Muni A | 4.91B | 0.24 | -0.01 | 1.62 | ||
AB Intermediate Diversified Muni Ad | 4.91B | 0.31 | 0.24 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Total Intl Stock Index Inv | 195.27B | 4.34 | 1.83 | 4.38 | ||
Vanguard Total Intl Stock Index Adm | 75.19B | 4.30 | 1.88 | 4.45 | ||
Fidelity International Index Inst | 50.02B | 5.79 | 4.96 | 4.94 | ||
Fidelity Series Global ex US Index | 45.57B | 4.69 | 1.96 | 4.28 | ||
Vanguard Total Intl Stock Index I | 40.77B | 4.32 | 1.91 | 4.48 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Roche Holding Participation | CH0012032048 | 2.81 | 221.00 | +1.01% | |
Partners Group | CH0024608827 | 1.61 | 1,195.00 | +1.19% | |
EDP | PTEDP0AM0009 | 1.42 | 3.523 | +0.83% | |
Ahold Delhaize | NL0011794037 | 1.35 | 28.00 | +0.43% | |
GlaxoSmithKline PLC | GB0009252882 | 1.30 | - | - |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review